When the host’s immune system is “primed” with CTLA-4 blockade to favor a balanced ratio of Teff cells >Tregs, a cytotoxic CD8+ T-cell response will predominate, resulting in conferred immunity to the cancer and regression of not only the primary tumor but of its metastatic deposits as well. The gene discussed is CTLA4; the disease is neoplasm.